- Home
- WTBA vs PRME Comparison
WTBA vs PRME Comparison
Compare WTBA & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WTBA | PRME |
|---|---|---|
| Founded | 1893 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 488.6M | 553.2M |
| IPO Year | 2002 | 2022 |
Fundamental Metrics
Financial Performance| Metric | WTBA | PRME |
|---|---|---|
| Price | $28.67 | $3.14 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $24.00 | $7.56 |
| AVG Volume (30 Days) | 36.3K | ★ 2.5M |
| Earning Date | 04-23-2026 | 05-08-2026 |
| Dividend Yield | ★ 4.17% | N/A |
| EPS Growth | ★ 35.21 | 18.18 |
| EPS | ★ 1.26 | N/A |
| Revenue | N/A | ★ $4,632,000.00 |
| Revenue This Year | $23.80 | $7.06 |
| Revenue Next Year | $9.39 | $47.01 |
| P/E Ratio | $23.18 | ★ N/A |
| Revenue Growth | N/A | ★ 55.28 |
| 52 Week Low | $19.03 | $2.67 |
| 52 Week High | $30.33 | $6.94 |
Technical Indicators
Market Signals| Indicator | WTBA | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 53.55 | 56.17 |
| Support Level | $27.54 | $3.14 |
| Resistance Level | $30.12 | $3.72 |
| Average True Range (ATR) | 0.48 | 0.22 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 38.04 | 63.44 |
Price Performance
Historical ComparisonAbout WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings, and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.